Product logins

Find logins to all Clarivate products below.


Alison Isherwood

Director, Epidemiology & Real-World Evidence

Dr. Alison Isherwood is a Director in Clarivate’s Commercial Strategy Consulting Epidemiology & Real-World Evidence team.

Alison has over 16 years of consultancy experience in healthcare and life sciences consultancy, specializing in epidemiological and RWE-based insights and solutions. Her role is to use secondary data and US and European real-world data (RWD) to provide strategic epidemiological insights for business stakeholders in commercial and HEOR roles.

Alison held the roles of Research Scientist at Evidera designing and executing RWE-based outcomes research studies. Prior to this, she the Director of Epidemiology for DRG’s Syndicated Epidemiology team where she gained considerable experience in patient population sizing with incidence and prevalence risk-based forecast modelling across a portfolio of 200 diseases in over 40 countries.

She holds a Doctoral degree from the University of Reading (UK), and an MSc in Epidemiology, an MRes in Life Sciences and a BSc in Medical Microbiology all from the University of Edinburgh.


arrow_forward
Get in touch with Alison

Related resources

AI驱动数据整理:原发性震颤流行病学迎来新方法 AI驱动数据整理:原发性震颤流行病学迎来新方法
Blog November 17, 2025
AI驱动数据整理:原发性震颤流行病学迎来新方法
药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇 药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇
Blog October 13, 2025
药物再定位、真实世界数据和人工智能/机器学习(AI/ML):前景与机遇
六家公司为“不可成药”靶点实现精准干预 六家公司为“不可成药”靶点实现精准干预
Blog October 7, 2025
六家公司为“不可成药”靶点实现精准干预
GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐 GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐
Blog October 3, 2025
GLP-1减肥药美国市场版图争夺已演变成一场激烈角逐